(Q38058833)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140239%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

Peripheral adrenoceptors: the impetus behind glucose dysregulation and insulin resistance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140239%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140239%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Alasdair M Barr

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140239%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

H N Boyda

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140239%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

C C Y Pang

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140239%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

1 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140239%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroendocrinology

17 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140239%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140239%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140239%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

217-228

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140239%20AND%20SRC:MED&resulttype=core&format=json

Insulin effects in muscle and adipose tissue

17 February 2020

cites work

1 reference

Diagnosis and classification of diabetes mellitus

21 January 2018

1 reference

Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose

21 January 2018

1 reference

Hepatic insulin resistance, metabolic syndrome and cardiovascular disease

21 January 2018

1 reference

Intermittent treatment with olanzapine causes sensitization of the metabolic side-effects in rats.

21 January 2018

1 reference

Preclinical models of antipsychotic drug-induced metabolic side effects.

21 January 2018

1 reference

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

21 January 2018

1 reference

Sympathetic overactivity precedes metabolic dysfunction in a fructose model of glucose intolerance in mice.

21 January 2018

1 reference

Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study

21 January 2018

1 reference

Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance

21 January 2018

1 reference

Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study

21 January 2018

1 reference

Signalling by insulin and IGF receptors: supporting acts and new players

21 January 2018

1 reference

Pathogenesis of type 2 diabetes mellitus

21 January 2018

1 reference

Incretin-based therapy: a powerful and promising weapon in the treatment of type 2 diabetes mellitus

21 January 2018

1 reference

The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes

21 January 2018

1 reference

Defining and characterizing the progression of type 2 diabetes

21 January 2018

1 reference

Facilitative glucose transporter 9 expression affects glucose sensing in pancreatic beta-cells

21 January 2018

1 reference

GLUT2 (SLC2A2) is not the principal glucose transporter in human pancreatic beta cells: implications for understanding genetic association signals at this locus

21 January 2018

1 reference

Carbohydrate response element-binding protein (ChREBP) plays a pivotal role in beta cell glucotoxicity

21 January 2018

1 reference

Insulin and glucagon regulate pancreatic α-cell proliferation

21 January 2018

1 reference

Glucotoxicity and α cell dysfunction: involvement of the PI3K/Akt pathway in glucose-induced insulin resistance in rat islets and clonal αTC1-6 cells

21 January 2018

1 reference

Physiologic action of glucagon on liver glucose metabolism

21 January 2018

1 reference

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

21 January 2018

1 reference

Regulation of hepatic and peripheral glucose disposal

21 January 2018

1 reference

Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis

21 January 2018

1 reference

Elevated glucose represses liver glucokinase and induces its regulatory protein to safeguard hepatic phosphate homeostasis

21 January 2018

1 reference

Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis

21 January 2018

1 reference

Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction

21 January 2018

1 reference

Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo

21 January 2018

1 reference

Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action.

21 January 2018

1 reference

FoxO6 integrates insulin signaling with gluconeogenesis in the liver.

21 January 2018

1 reference

Association of common genetic variation in the FOXO1 gene with beta-cell dysfunction, impaired glucose tolerance, and type 2 diabetes

21 January 2018

1 reference

Basal hepatic glucose production is regulated by the portal vein insulin concentration.

21 January 2018

1 reference

Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production

21 January 2018

1 reference

Hypothalamic insulin signaling is required for inhibition of glucose production

21 January 2018

1 reference

Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.

21 January 2018

1 reference

Regulation of glucose transport by insulin: traffic control of GLUT4.

21 January 2018

1 reference

GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes

21 January 2018

1 reference

Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21.

21 January 2018

1 reference

Adipocytes as regulators of energy balance and glucose homeostasis

21 January 2018

1 reference

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases

21 January 2018

1 reference

Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B.

21 January 2018

1 reference

Hyperinsulinemia increases the amount of GLUT4 mRNA in white adipose tissue and decreases that of muscles: a clue for increased fat depot and insulin resistance.

21 January 2018

1 reference

Insulin regulates adipocyte lipolysis via an Akt-independent signaling pathway

21 January 2018

1 reference

Involvement of alpha1 and beta-adrenoceptors in adrenaline stimulation of the glucagon-secreting mouse alpha-cell

21 January 2018

1 reference

Regulation of catecholamine release in human adrenal chromaffin cells by β-adrenoceptors

21 January 2018

1 reference

alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling

21 January 2018

1 reference

Knockout of the alpha 1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure

21 January 2018

1 reference

The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction.

21 January 2018

1 reference

alpha1A-adrenoceptors activate glucose uptake in L6 muscle cells through a phospholipase C-, phosphatidylinositol-3 kinase-, and atypical protein kinase C-dependent pathway

21 January 2018

1 reference

Epinephrine-dependent control of glucose metabolism in white adipose tissue: the role of α- and β-adrenergic signalling.

21 January 2018

1 reference

In vivo response to alpha(1)-adrenoreceptor stimulation in human white adipose tissue

21 January 2018

1 reference

Sympathetic regulation of glucose uptake by the alpha1-adrenoceptor in human obesity

21 January 2018

1 reference

Impaired glucose homeostasis in mice lacking the alpha1b-adrenergic receptor subtype

21 January 2018

1 reference

α2-adrenoceptor regulation of blood glucose homeostasis.

21 January 2018

1 reference

Pharmacologic and therapeutic applications of alpha 2-adrenoceptor subtypes

21 January 2018

1 reference

Inhibition of insulin secretion via distinct signaling pathways in alpha2-adrenoceptor knockout mice

21 January 2018

1 reference

Proteomic exploration of pancreatic islets in mice null for the alpha2A adrenergic receptor

21 January 2018

1 reference

Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes

21 January 2018

1 reference

The rs553668 polymorphism of the ADRA2A gene predicts the worsening of fasting glucose values in a cohort of subjects without diabetes. A population-based study.

21 January 2018

1 reference

Adrenergic regulation of adipocyte metabolism

21 January 2018

1 reference

Involvement of α2-adrenoceptor subtypes A and C in glucose homeostasis and adrenaline-induced hyperglycaemia.

21 January 2018

1 reference

Time to re-appraise the role of alpha-1 adrenoceptor antagonists in the management of hypertension?

21 January 2018

1 reference

Effect of an oral α2-adrenergic blocker (MK-912) on pancreatic islet function in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

Chronic renin inhibition with aliskiren improves glucose tolerance, insulin sensitivity, and skeletal muscle glucose transport activity in obese Zucker rats

21 January 2018

1 reference

Greater glycogen utilization during 1- than 2-adrenergic receptor stimulation in the isolated perfused rat heart

21 January 2018

1 reference

Concentration-dependent effects of adrenaline on the profile of insulin secretion from isolated human islets of Langerhans

21 January 2018

1 reference

Selective stimulation of glucagon secretion by beta 2-adrenoceptors in isolated islets of Langerhans of the rat.

21 January 2018

1 reference

Epinephrine-induced insulin resistance in man.

21 January 2018

1 reference

Multiple signalling pathways involved in beta2-adrenoceptor-mediated glucose uptake in rat skeletal muscle cells.

21 January 2018

1 reference

Clenbuterol prevents epinephrine from antagonizing insulin-stimulated muscle glucose uptake

21 January 2018

1 reference

β(2)-Adrenoceptors increase translocation of GLUT4 via GPCR kinase sites in the receptor C-terminal tail

21 January 2018

1 reference

Catecholamine regulation of local lactate production in vivo in skeletal muscle and adipose tissue: role of -adrenoreceptor subtypes

21 January 2018

1 reference

Adrenergic receptor stimulation attenuates insulin-stimulated glucose uptake in 3T3-L1 adipocytes by inhibiting GLUT4 translocation

21 January 2018

1 reference

Molecular characterization of the human beta 3-adrenergic receptor

21 January 2018

1 reference

Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells

21 January 2018

1 reference

Sustained improvement in glucose homeostasis in lean and obese mice following chronic administration of the beta 3 agonist SR 58611A.

21 January 2018

1 reference

Biphasic effects of the beta-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle

21 January 2018

1 reference

Reversal of high pancreatic islet and white adipose tissue blood flow in type 2 diabetic GK rats by administration of the beta3-adrenoceptor inhibitor SR-59230A.

21 January 2018

1 reference

beta-Agonists and metabolism

21 January 2018

1 reference

Effects of beta-blockers on glucose and lipid metabolism

21 January 2018

1 reference

Metabolic effects of beta-adrenoceptor antagonists with special emphasis on carvedilol

21 January 2018

1 reference

Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.

21 January 2018

1 reference

Differential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome

21 January 2018

1 reference

β-AR polymorphisms and glycemic and lipid parameters in hypertensive individuals receiving carvedilol or metoprolol

21 January 2018

1 reference